Foot ulcers are common among the 30 million Americans suffering from diabetes. They're the main cause of lower limb amputations, according to the Centers for Disease Control. With diabetes projected to rise to half a billion people worldwide, the need for improved screening and earlier intervention in diabetic foot disease is critical. That's why we're learning about the importance of early intervention, and how an innovative screening device from HyperMed Imaging can potentially help patients stay one step ahead . HyperMed Imaging, Inc. is the established leader in medical hyperspectral imaging for surface tissue oximetry. Their pioneering technology has been in service since 2006 and has been shown in published clinical research to effectively assess oxyhemoglobin, deoxyhemoglobin, and oxyhemoglobin saturation in superficial tissue for a number of key healthcare applications. By imaging oxyhemoglobin and deoxyhemoglobin levels, as well as oxygen saturation in superficial tissue, the
